The Strasbourg site is located in the Illkirsh-Graffenstaden Innovation Park.
Covering an area of 4900 sq meters, the site has been the first viral vectors facility in Europe (1994).
The facility has been specialized in viral vectors development and manufacturing for 25+ years. Equipped with four independent suites focusing on development and scalable production, our capabilities are fully flexible to support your innovation and make your project a success. A dedicated fill & finish suite for the manufacturing of your drug product can manage up to 10,000 vials/batch.
Our integrated Quality Control laboratory is operational design and execute a detailed and robust process and analytical development plan, phase appropriate, accordingly to your product specification and overall project milestones.
Our team of experts bring extensive experience in viral vectors field.
Suite 1 : Grade A/C
Suspended & adherent (microcarriers) cells
Suite 2 : Grade A/B
Suite 3 : F&F. Isolator Grade A/C
Process development & process transfer
QC laboratories: ~400 sqm and 38 analytical experts